Back to search
FDAFDA · Food and drugs·Recall number Z-2308-2012

Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use.

Published September 12, 2012 · Recall initiated: March 9, 2012

Summary

FDA records medical device Class II recall Z-2308-2012, published September 12, 2012 and initiated March 9, 2012. Recalling firm: Princeton Biomeditech Corp; Status: Terminated; Reported quantity: 90 kits (22 tests per kit); Lot: 510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There have been reports of dual positive (Flu A + Flu B positive) results being encountered.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Princeton Biomeditech Corp
Distributor
Nationwide Distribution-including the states of NJ, NY, and PA.
Lot
510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit)
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use. recalled?

Yes. FDA published recall Z-2308-2012 on September 12, 2012. Reported hazard: There have been reports of dual positive (Flu A + Flu B positive) results being encountered.

What should I do if I have this product?

Voluntary: Firm initiated · Letter